Elizabeth Mullen, MD, FAAP
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Assistant Professor of Pediatrics, Harvard Medical School
Image
Elizabeth Mullen, MD, FAAP
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Assistant Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Medical School
Yale University School of Medicine
1992
New Haven
CT
Internship
Pediatrics
Boston Children's Hospital
1993
Boston
MA
Residency
Pediatrics
Boston Combined Residency Program (BCRP)
1995
Boston
MA
Fellowship
Pediatric Hematology-Oncology
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
1997
Boston
MA
Certifications
American Board of Pediatrics (Hematology-Oncology)
Publications
Wilms Tumor in Children with AMER1/WTX Germline Pathogenic Variants: A Multicenter Case Series. View Abstract
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives. View Abstract
Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor: A Pooled Analysis of Children's Oncology Group Studies AREN0532 and AREN03B2. View Abstract
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers. View Abstract
Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies. View Abstract
Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study-5 and Children's Oncology Group Study AREN0321. View Abstract
Outcomes of relapsed favorable-histology Wilms tumor in non-clinical trial setting. View Abstract
BRAF Exon 15 Mutations in the Evaluation of Well-Differentiated Epithelial Nephroblastic Neoplasms in Children: A Report From the Children's Oncology Group Study AREN03B2. View Abstract
Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. View Abstract
Response of bilateral Wilms tumor to chemotherapy suggests histologic subtype and guides treatment. View Abstract
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. View Abstract
Long-term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study. View Abstract
Anaplastic sarcoma of the kidney (DICER1-sarcoma of the kidney): A report from the International Pleuropulmonary Blastoma/DICER1 Registry. View Abstract
Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534. View Abstract
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin. View Abstract
Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2. View Abstract
Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2. View Abstract
Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q. View Abstract
Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5. View Abstract
Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532. View Abstract
Hallmark discoveries in the biology of Wilms tumour. View Abstract
Children's Oncology Group's 2023 blueprint for research: Renal tumors. View Abstract
Severe Hepatopathy in National Wilms Tumor Studies 3-5: Prevalence, Clinical Features, and Outcomes After Reintroduction of Chemotherapy. View Abstract
A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors. View Abstract
Tolerability of ifosfamide-containing regimen in patients with high-risk renal and INI-1-deficient tumors. View Abstract
The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study. View Abstract
Late Health Outcomes Among Survivors of Wilms Tumor Diagnosed Over Three Decades: A Report From the Childhood Cancer Survivor Study. View Abstract
The varied spectrum of nephroblastomatosis, nephrogenic rests, and Wilms tumors: Review of current definitions and challenges of the field. View Abstract
Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study. View Abstract
Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533. View Abstract
White paper: Oncofertility in pediatric patients with Wilms tumor. View Abstract
ASO Video Abstract: Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis-A Report from the Children's Oncology Group Study AREN0534. View Abstract
Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534). View Abstract
Authors' Reply to the Letter to the Editor by Daniel M. Green. View Abstract
Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534. View Abstract
Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor. View Abstract
Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. View Abstract
Haplotype-resolved germline and somatic alterations in renal medullary carcinomas. View Abstract
Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumors. View Abstract
Phase I/II Study of Stereotactic Body Radiation Therapy for Pulmonary Metastases in Pediatric Patients. View Abstract
A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study. View Abstract
The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. View Abstract
Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group. View Abstract
DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor. View Abstract
Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children's Oncology Group study AREN03B2. View Abstract
Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2. View Abstract
Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study. View Abstract
Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers. View Abstract
50 Years Ago in TheJournal ofPediatrics: 50 years of progress in renal cell carcinoma: From case reports to targeted therapy. View Abstract
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report. View Abstract
Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor. View Abstract
Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study. View Abstract
Reply to L. Xie et al. View Abstract
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition. View Abstract
Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. View Abstract
Reply to D.M. Green. View Abstract
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma. View Abstract
Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors. View Abstract
The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing. View Abstract
Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. View Abstract
Reply to B. Zhang et al. View Abstract
Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. View Abstract
Erratum: PGBD5 promotes site-specific oncogenic mutations in human tumors. View Abstract
Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group. View Abstract
Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group. View Abstract
Renal Medullary Carcinoma: Establishing Standards in Practice. View Abstract
PGBD5 promotes site-specific oncogenic mutations in human tumors. View Abstract
Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532. View Abstract
Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan. View Abstract
Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. View Abstract
Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group. View Abstract
Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations. View Abstract
Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. View Abstract
Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2. View Abstract
Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group. View Abstract
Feasibility of using CT volume as a predictor of specimen weight in a subgroup of patients with low risk Wilms tumors registered on COG Study AREN03B2: implications for central venous catheter placement. View Abstract
DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. View Abstract
Inter-rater reliability of surgical reviews for AREN03B2: a COG renal tumor committee study. View Abstract
Uncle Sam and your job options. Considering your next career move? Consider the tax implications. View Abstract
Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee. View Abstract
Children's Oncology Group's 2013 blueprint for research: renal tumors. View Abstract
Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology Group. View Abstract
Barriers to the enrollment of children in the Children's Oncology Group study of very low risk Wilms tumor: a report from the Children's Oncology Group. View Abstract
The impact of surveillance imaging on overall survival in patients with recurrent Wilms tumor: A report from the Children's Oncology Group. View Abstract
Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study. View Abstract
Pediatric Oncologic Emergencies View Abstract
The effects of postoperative pain and its management on postoperative cognitive dysfunction. View Abstract
Exploring the psychological underpinnings of the moral mandate effect: motivated reasoning, group differentiation, or anger? View Abstract
Postoperative delirium: the importance of pain and pain management. View Abstract
Universal session-level change processes in an early session of psychotherapy: path models. View Abstract
Section Editor, Oncology View Abstract
Oncologic Emergencies Chapter View Abstract
Section Editor, Oncology View Abstract
The Safety of Oral Magnesium Pidolate in Children with Hemoglobin SC Disease View Abstract
Multiple micronutrient deficiencies in a child fed an elemental formula. View Abstract
Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Acute Chest View Abstract
Multiple Micronutrient Deficiencies in a Child Fed an Elemental Formula View Abstract
Clinical Practice Guidelines on the treatment of patients with Sickle Cell Disease, on the topic of Transfusion View Abstract
Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Pain View Abstract
Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Splenic Sequestration View Abstract
Clinical Practice Guidelines for the treatment of Fever in Sickle Cell Disease View Abstract
Clinical Practice Guidelines for the treatment of Fever and Neutropenia View Abstract
Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Fever View Abstract
Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Routine Health Maintainence and Priapism View Abstract
Clinical Practice Guidelines for the treatment of Pain in Sickle Cell Disease View Abstract
Multiple Mechanisms of Cell Injury in the Gastric Mucosa View Abstract
Biochemical Characterization of a Boving Corneal Angiogenesis Inhibitor View Abstract
Fluorogenic Assay of Proteinase Activity in Developing Rat Enamel View Abstract
Abundant Occurrence of Gamma-Carboxyglutamic Acid-Containing Peptides in the Gastropod Family View Abstract
An examination of the Vitamin K Cycle: Phenytoin Interference in K-dependent Carboxylase Activity View Abstract